Hypoadiponectinemia is associated with insulin resistance and glucose intolerance after renal transplantation:: Impact of immunosuppressive and antihypertensive drug therapy

被引:30
作者
Hjelmesaeth, Joran
Flyvbjerg, Allan
Jenssen, Trond
Frystyk, Jan
Ueland, Thor
Hagen, Monica
Hartmann, Anders
机构
[1] Hosp Vestfold, Dept Med, N-3103 Tonsberg, Norway
[2] Univ Hosp, Rikshosp, Dept Med, Oslo, Norway
[3] Univ Hosp, Rikshosp, Internal Med Res Inst, Oslo, Norway
[4] Aarhus Univ Hosp, Inst Clin, Med Res Labs, DK-8000 Aarhus, Denmark
[5] Aarhus Univ Hosp, Dept Med M Diabet & Endocrinol, DK-8000 Aarhus, Denmark
[6] Univ Tromso, Inst Clin Med, N-9001 Tromso, Norway
来源
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2006年 / 1卷 / 03期
关键词
D O I
10.2215/CJN.01471005
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The objectives of this analysis were (1) to assess whether low serum adiponectin concentrations are associated with insulin resistance, metabolic syndrome, and new-onset posttransplantation diabetes mellitus (PTDM) and (2) to examine the possible effects of immunosuppressive and antiltypertensive therapies on circulating adiponectin levels after renal transplantation. A total of 172 consecutive previously nondiabetic renal transplant recipients were examined 3 mo after transplantation, the majority (n = 167) with an oral glucose tolerance test. Serum adiponectin was measured by an in-house time-resolved immunofluorometric assay. Insulin secretion and insulin sensitivity were estimated by previously validated oral glucose tolerance test-derived indexes. One- and 6-yr follow-up data were available in subgroups of patients. Lower adiponectin levels were significantly associated with insulin resistance but not with insulinopenia. Patients with low adiponectin levels (first quartile) had significantly higher odds of PTDM (odds ratio [OR] 3.6; 95% confidence interval [CI] 1.1 to 12.7; P = 0.049) and metabolic syndrome (OR 3.9; 95% CI 1.6 to 9.5; P = 0.003) than patients in the upper (fourth) quartile. The increased risk for PTDM in patients with low adiponectin levels remained significant after adjustment for age, steroid dose, and family history of diabetes. Treatment with 13 blockers was independently associated with lower serum adiponectin levels, and total steroid dose was associated with higher serum adiponectin levels. Low baseline adiponectin levels were also associated with significantly higher odds of PTDM at 6 yr (OR 6.9; 95% CI = 1.1 to 41.8; P = 0.037). Serum adiponectin levels correlate with posttransplantation insulin sensitivity and glucose tolerance. Glucocorticoids and 0 blockers seem to have opposite effects on circulating adiponectin levels.
引用
收藏
页码:575 / 582
页数:8
相关论文
共 48 条
[1]  
Amer Diabet Assoc, 2005, DIABETES CARE, V28, pS37
[2]   Identification of regulatory elements in the human adipose most abundant gene transcript-1 (apM-1) promoter:: role of SP1/SP3 and TNF-α as regulatory pathways [J].
Barth, N ;
Langmann, T ;
Schölmerich, J ;
Schmitz, G ;
Schäffler, A .
DIABETOLOGIA, 2002, 45 (10) :1425-1433
[3]   Adiponectin and risk of new-onset diabetes mellitus after kidney transplantation [J].
Bayés, B ;
Lauzurica, R ;
Granada, ML ;
Serra, A ;
Bonet, L ;
Fontseré, N ;
Salinas, I ;
Romero, R .
TRANSPLANTATION, 2004, 78 (01) :26-30
[4]   Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: The mild and moderate kidney disease study [J].
Becker, B ;
Kronenberg, F ;
Kielstein, JT ;
Haller, H ;
Morath, C ;
Ritz, E ;
Fliser, D .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (04) :1091-1098
[5]   Accurate assessment of β-cell function -: The hyperbolic correction [J].
Bergman, RN ;
Ader, M ;
Huecking, K ;
Van Citters, G .
DIABETES, 2002, 51 :S212-S220
[6]   Plasma adiponectin concentration before and after successful kidney transplantation [J].
Chudek, J ;
Adamczak, M ;
Karkoszka, H ;
Budzinski, G ;
Ignacy, W ;
Funahashi, T ;
Matsuzawa, Y ;
Cierpka, L ;
Kokot, F ;
Wiecek, A .
TRANSPLANTATION PROCEEDINGS, 2003, 35 (06) :2186-2189
[7]   Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin [J].
Combs, TP ;
Berg, AH ;
Rajala, MW ;
Klebanov, S ;
Iyengar, P ;
Jimenez-Chillaron, JC ;
Patti, ME ;
Klein, SL ;
Weinstein, RS ;
Scherer, PE .
DIABETES, 2003, 52 (02) :268-276
[8]  
Corry DB, 1996, AM J NEPHROL, V16, P223
[9]   INSULIN RESISTANCE AND INSULIN DEFICIENCY IN THE PATHOGENESIS OF POSTTRANSPLANTATION DIABETES IN MAN [J].
EKSTRAND, AV ;
ERIKSSON, JG ;
GRONHAGENRISKA, C ;
AHONEN, PJ ;
GROOP, LC .
TRANSPLANTATION, 1992, 53 (03) :563-568
[10]   Effect of glucocorticoids on adiponectin: a study in healthy subjects and in Cushing's syndrome [J].
Fallo, F ;
Scarda, A ;
Sonino, N ;
Paoletta, A ;
Boscaro, M ;
Pagano, C ;
Federspil, G ;
Vettor, R .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2004, 150 (03) :339-344